2019 Q1 Form 10-Q Financial Statement

#000110465919026396 Filed on May 02, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q1
Revenue $37.95B $14.30B $11.41B
YoY Change 232.48% 34.5% 9.45%
Cost Of Revenue $24.05B $561.0M
YoY Change 4186.99%
Gross Profit $13.90B $10.85B
YoY Change 28.05%
Gross Profit Margin 36.62% 95.08%
Selling, General & Admin $3.303B $2.745B
YoY Change 20.33%
% of Gross Profit 23.77% 25.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $897.0M $257.0M $140.0M
YoY Change 540.71% 82.27% -4.11%
% of Gross Profit 6.46% 1.29%
Operating Expenses $3.303B $13.53B $2.745B
YoY Change 20.33% 36.7% -71.36%
Operating Profit $2.230B $1.308B
YoY Change 70.49%
Interest Expense -$452.0M -$498.0M -$57.00M
YoY Change 692.98%
% of Operating Profit -20.27% -4.36%
Other Income/Expense, Net -$452.0M -$57.00M
YoY Change 692.98%
Pretax Income $1.788B $228.0M $1.218B
YoY Change 46.8% -69.92% 36.85%
Income Tax $416.0M $80.00M $301.0M
% Of Pretax Income 23.27% 35.09% 24.71%
Net Earnings $1.372B $144.0M $917.0M
YoY Change 49.62% -45.86% 53.34%
Net Earnings / Revenue 3.62% 1.01% 8.03%
Basic Earnings Per Share $3.61 $0.56 $3.78
Diluted Earnings Per Share $3.56 $0.55 $3.72
COMMON SHARES
Basic Shares Outstanding 380.1M shares
Diluted Shares Outstanding 384.0M shares 245.8M shares

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.976B $3.855B $2.771B
Short-Term Investments
Other Short-Term Assets $1.175B $1.236B
YoY Change 50.73%
Inventory $2.382B $2.821B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $21.14B $20.43B
YoY Change 119.42%
LONG-TERM ASSETS
Property, Plant & Equipment $4.523B $4.562B $1.552B
YoY Change 191.43% 191.87% 2.17%
Goodwill $44.54B $44.51B
YoY Change 622.01%
Intangibles $38.34B $39.00B
YoY Change 11205.22%
Long-Term Investments $28.92B $28.97B $29.86B
YoY Change -3.16% 1.24% 9.56%
Other Assets $2.276B $1.630B $96.00M
YoY Change 2270.83% 13.91% -63.5%
Total Long-Term Assets $133.2B $132.8B
YoY Change 153.2%
TOTAL ASSETS
Total Short-Term Assets $21.14B $20.43B
Total Long-Term Assets $133.2B $132.8B
Total Assets $154.3B $153.2B $63.14B
YoY Change 144.45% 148.1% 3.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.488B $4.366B $7.825B
YoY Change -42.65% 2272.83% 17.37%
Accrued Expenses $7.885B $7.071B
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $558.0M $0.00 $100.0M
YoY Change 458.0% -100.0%
Long-Term Debt Due $2.357B $0.00 $10.00M
YoY Change 23470.0% -100.0% -92.96%
Total Short-Term Liabilities $32.97B $31.90B $10.86B
YoY Change 203.58% 189.72% 13.37%
LONG-TERM LIABILITIES
Long-Term Debt $37.57B $39.52B $5.191B
YoY Change 623.77% 660.2% 12.33%
Other Long-Term Liabilities $3.832B $3.470B
YoY Change 22.27%
Total Long-Term Liabilities $3.832B $42.99B $5.191B
YoY Change -26.18% 1414.9% 12.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.97B $31.90B $10.86B
Total Long-Term Liabilities $3.832B $42.99B $5.191B
Total Liabilities $111.9B $112.2B $48.95B
YoY Change 128.61% 133.66% 4.32%
SHAREHOLDERS EQUITY
Retained Earnings $16.43B $15.09B
YoY Change -4.51%
Common Stock $27.86B $27.76B
YoY Change 820.87%
Preferred Stock
YoY Change
Treasury Stock (at cost) $595.0M $104.0M
YoY Change -97.41%
Treasury Stock Shares 3.600M shares 570.0K shares
Shareholders Equity $42.41B $41.03B $14.20B
YoY Change
Total Liabilities & Shareholders Equity $154.3B $153.2B $63.14B
YoY Change 144.45% 148.1% 3.26%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q1
OPERATING ACTIVITIES
Net Income $1.372B $144.0M $917.0M
YoY Change 49.62% -45.86% 53.34%
Depreciation, Depletion And Amortization $897.0M $257.0M $140.0M
YoY Change 540.71% 82.27% -4.11%
Cash From Operating Activities $3.192B $126.0M $2.025B
YoY Change 57.63% -78.09% 28.25%
INVESTING ACTIVITIES
Capital Expenditures $194.0M -$182.0M $103.0M
YoY Change 88.35% 38.93% -213.19%
Acquisitions $6.000M $0.00
YoY Change
Other Investing Activities $0.00 -$24.52B -$1.597B
YoY Change -100.0% 5095.34% 6042.31%
Cash From Investing Activities $475.0M -$24.70B -$1.700B
YoY Change -127.94% 3996.85% 1352.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $409.0M $290.0M
YoY Change 41.03%
Debt Paid & Issued, Net $1.000B $131.0M
YoY Change 663.36% -47.6%
Cash From Financing Activities -$2.534B 4.400B -$530.0M
YoY Change 378.11% -744.22% 2.91%
NET CHANGE
Cash From Operating Activities $3.192B 126.0M $2.025B
Cash From Investing Activities $475.0M -24.70B -$1.700B
Cash From Financing Activities -$2.534B 4.400B -$530.0M
Net Change In Cash $1.121B -20.18B -$201.0M
YoY Change -657.71% 2737.97% -121.22%
FREE CASH FLOW
Cash From Operating Activities $3.192B $126.0M $2.025B
Capital Expenditures $194.0M -$182.0M $103.0M
Free Cash Flow $2.998B $308.0M $1.922B
YoY Change 55.98% -56.37% 15.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3855000000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4562000000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
44505000000 USD
CY2018Q4 us-gaap Separate Account Assets
SeparateAccountAssets
7839000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
23169000000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22928000000 USD
CY2019Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
1864000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41035000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13711000000 USD
CY2018Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
37000000 USD
CY2017Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
49000000 USD
CY2019Q1 us-gaap Nature Of Operations
NatureOfOperations
<div><p style='text-align:justify;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0pt;color:#000000;' >Note </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' >1</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > &#8211; Description of Business</font></p><p style='text-align:justify;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >Cigna Corporation, together with its subsidiaries (either individually or collectively referred to as &#8220;Cigna,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;)</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >is a global health service organization dedicated to a mission of </font><font style='font-family:Times New Roman;font-size:10pt;' >helping those we serve improve their health, well-being and peace of mind. Our evolved strategy in support of our mission is </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;' >Go Deeper, Go Local, Go Beyond</font><font style='font-family:Times New Roman;font-size:10pt;' > using </font><font style='font-family:Times New Roman;font-size:10pt;' >a differentiated set of </font><font style='font-family:Times New Roman;font-size:10pt;' >pharmacy</font><font style='font-family:Times New Roman;font-size:10pt;' >,</font><font style='font-family:Times New Roman;font-size:10pt;' > </font><font style='font-family:Times New Roman;font-size:10pt;' >medical, </font><font style='font-family:Times New Roman;font-size:10pt;' >dental, disability, life and accident insurance</font><font style='font-family:Times New Roman;font-size:10pt;' > an</font><font style='font-family:Times New Roman;font-size:10pt;' >d related products and services</font><font style='font-family:Times New Roman;font-size:10pt;' > offered by our subsidiaries</font><font style='font-family:Times New Roman;font-size:10pt;' >.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna also offers commercial heal</font><font style='font-family:Times New Roman;font-size:10pt;' >th and dental insurance, Medicare and Medicaid products and health, life and accident insurance coverages to individuals in the United States and selected international markets. In addition to these ongoing operations, Cigna also has certain run-off opera</font><font style='font-family:Times New Roman;font-size:10pt;' >tions.</font></p></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;' >As described more fully in Note </font><font style='font-family:Times New Roman;font-size:10pt;' >4</font><font style='font-family:Times New Roman;font-size:10pt;' >, o</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >n December 20, 2018, Cigna completed the acquisition of Express Scripts Holding Company (&#8220;Express Scripts&#8221;). </font><font style='font-family:Times New Roman;font-size:10pt;' >As a result, our </font><font style='font-family:Times New Roman;font-size:10pt;' >segments have changed as described below, effective in the fourth quarter of 2018. </font><font style='font-family:Times New Roman;font-size:10pt;' >Prior year f</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >inancial data presented </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >in this Form 10-Q has been</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > re</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >stated to reflect this new segment </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >presentation</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;color:#000000;' >Health Services </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >includes pharmacy benefits management, pharmacy home delivery and certain medical management services. This segment includes</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > Express Scripts&#8217; business from the date of acquisition with the exception of Express Scripts&#8217; Medicare Part D business that is reported in the Government operating segment.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;color:#000000;' >Integrated Medical</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > offers a variety of medical solutions to employers and individ</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >uals.</font></p><p style='text-align:left;line-height:12pt;' ></p><ul style='margin-top:0pt;' ><li style='list-style:disc;text-align:left;margin-top:0pt;margin-bottom:0pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Commercial</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > operating segment serves employers (also referred to as &#8220;clients&#8221;) and their employees (also referred to as &#8220;customers&#8221;) and other groups. This segment provides deeply integrated medical and specialty offerings including medical, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >pharmacy, dental, behavioral health and vision, health advocacy programs and other products and services to insured and self-insured clients.</font></li><li style='list-style:disc;text-align:left;margin-top:0pt;margin-bottom:0pt;' ><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' > Government </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >operating segment offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medi</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >care-eligible beneficiaries as well as Medicaid plans. This operating segment also offers health insurance coverage to individual customers both on and off public exchanges. This segment includes the acquired Express Scripts&#8217; Medicare Part D business.</font></li></ul><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;color:#000000;' >I</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >nternational Markets </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >includes supplemental health, life and accident insurance products and health care coverage in our international markets as well as health care benefits to globally mobile employees of multinational organizations.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:0pt;color:#000000;' >The remainder of our</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > business operations are reported in </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Group Disability and Other, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >consisting of the following:</font></p><p style='text-align:left;line-height:12pt;' ></p><ul style='margin-top:0pt;' ><li style='list-style:disc;text-align:left;margin-top:0pt;margin-bottom:0pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Group Disability and Life</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > provides group long-term and short-term disability, group life, accident, voluntary and specialty insurance products and related servic</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >es.</font></li></ul><ul style='margin-top:0pt;' ><li style='list-style:disc;text-align:left;margin-top:0pt;margin-bottom:0pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Corporate-Owned Life Insurance (&#8220;COLI&#8221;)</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > offers </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for the purpose of financing employer-paid future benefit obligations.</font></li></ul><ul style='margin-top:0pt;' ><li style='list-style:disc;text-align:left;margin-top:0pt;margin-bottom:0pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Run-off businesses:</font></li></ul></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Reinsurance:</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > predominantly comprised of guaranteed minimum death benefit (&#8220;GMDB&#8221;) and guaranteed minimum income benefit (&#8220;GMIB&#8221;) business effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska (&#8220;Berkshire&#8221;) in 20</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >13.</font></p></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Settlement Annuity</font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >business in run-off.</font></p></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Individual Life Insurance and Annuity and Retirement Benefits Businesses:</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > deferred gains from the sales of these businesses.</font></p></div><p style='line-height:20pt;' /><div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;color:#000000;' >Certain international run-off businesses</font></p></div><p style='line-height:20pt;' /><div><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;color:#000000;' >Corporate</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >reflects amounts not allocated to </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >operating segments, including interest expense</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > net investment income on investments not supporting segment </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >and other </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >operations, interest on uncertain tax positions, certain litigation matters, expense associated with our fr</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ozen pension plans, severance, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >certain enterprise-wide projects and </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >intersegment eliminations</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > for products and services sold between segments</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >.</font></p></div>
CY2019Q1 us-gaap Commercial Paper
CommercialPaper
558000000 USD
CY2018Q4 us-gaap Commercial Paper
CommercialPaper
1500000000 USD
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
21000000 USD
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
117000000 USD
CY2019Q1 ci Maximum Percent Level2 Investments Foreign Bonds Broker Quote
MaximumPercentLevel2InvestmentsForeignBondsBrokerQuote
0.01 pure
CY2019Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
USD
CY2018Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
USD
CY2019Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
USD
CY2018Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
USD
CY2019Q1 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
468000000 USD
CY2019Q1 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6918000000 USD
CY2019Q1 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
7386000000 USD
CY2019Q1 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
693000000 USD
CY2018Q4 ci Guaranteed Separate Account Assets
GuaranteedSeparateAccountAssets
454000000 USD
CY2018Q4 ci Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy
NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy
6653000000 USD
CY2018Q4 ci Separate Account Assets Classified In Fair Value Hierarchy
SeparateAccountAssetsClassifiedInFairValueHierarchy
7107000000 USD
CY2018Q4 ci Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient
NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient
732000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1366000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
6516000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9529000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
4231000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
494000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1370000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6684000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
9682000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4925000000 USD
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
508000000 USD
CY2019Q1 ci Available For Sale Securities Fixed Maturities Fair Value Excluding Trading Hybrid
AvailableForSaleSecuritiesFixedMaturitiesFairValueExcludingTradingHybrid
23169000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
22550000000 USD
CY2019Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1178000000 USD
CY2019Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
145000000 USD
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
474000000 USD
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
852000000 USD
CY2019Q1 us-gaap Variable Interest Entity Methodology For Determining Whether Enterprise Is Primary Beneficiary
VariableInterestEntityMethodologyForDeterminingWhetherEnterpriseIsPrimaryBeneficiary
When the Company becomes involved with a variable interest entity and when there is a change in the Company’s involvement with an entity, the Company must determine if it is the primary beneficiary and must consolidate the entity. The Company is considered the primary beneficiary if it has the power to direct the entity’s most significant economic activities or has the right to receive benefits or obligation to absorb losses that could be significant to the entity. The Company evaluates the following criteria: the structure and purpose of the entity; the risks and rewards created by and shared through the entity; and the Company’s ability to direct its activities, receive its benefits and absorb its losses relative to the other parties involved with the entity including its sponsors, equity holders, guarantors, creditors and servicers.
CY2019Q1 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
137000000 USD
CY2018Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
50000000 USD
CY2019Q1 ci Acquiror Merger Agreement Termination Fee Regulatory Approval Not Attained
AcquirorMergerAgreementTerminationFeeRegulatoryApprovalNotAttained
1850000000 USD
CY2019Q1 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
58000000 USD
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001739940
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Investment Redemption Frequency
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareInvestmentRedemptionFrequency
Quarterly redemption frequency
CY2019Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2045000000 USD
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
10473000000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
2821000000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1236000000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
20430000000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
26929000000 USD
CY2018Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
2821000000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1630000000 USD
CY2018Q4 us-gaap Assets
Assets
153226000000 USD
CY2018Q4 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
6801000000 USD
CY2018Q4 us-gaap Debt Current
DebtCurrent
2955000000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31895000000 USD
CY2018Q4 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
19974000000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3470000000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39523000000 USD
CY2018Q4 us-gaap Separate Accounts Liability
SeparateAccountsLiability
7839000000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
112154000000 USD
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
37000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
41028000000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
153226000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2972000000 USD
CY2019Q1 ci Policyholder Contract Deposits Current
PolicyholderContractDepositsCurrent
621000000 USD
CY2019Q1 ci Liability For Future Policy Benefits Current
LiabilityForFuturePolicyBenefitsCurrent
643000000 USD
CY2019Q1 ci Unearned Premiums Current
UnearnedPremiumsCurrent
432000000 USD
CY2019Q1 ci Policyholder Contract Deposits Noncurrent
PolicyholderContractDepositsNoncurrent
7326000000 USD
CY2019Q1 ci Liability For Future Policy Benefits Noncurrent
LiabilityForFuturePolicyBenefitsNoncurrent
9048000000 USD
CY2019Q1 ci Unearned Premiums Noncurrent
UnearnedPremiumsNoncurrent
347000000 USD
CY2019Q1 us-gaap Policyholder Contract Deposits
PolicyholderContractDeposits
7947000000 USD
CY2019Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
9691000000 USD
CY2019Q1 us-gaap Unearned Premiums
UnearnedPremiums
779000000 USD
CY2019Q1 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
27103000000 USD
CY2018Q4 ci Policyholder Contract Deposits Current
PolicyholderContractDepositsCurrent
641000000 USD
CY2018Q4 ci Liability For Future Policy Benefits Current
LiabilityForFuturePolicyBenefitsCurrent
740000000 USD
CY2018Q4 ci Unearned Premiums Current
UnearnedPremiumsCurrent
348000000 USD
CY2018Q4 ci Policyholder Contract Deposits Noncurrent
PolicyholderContractDepositsNoncurrent
7365000000 USD
CY2018Q4 ci Liability For Future Policy Benefits Noncurrent
LiabilityForFuturePolicyBenefitsNoncurrent
8981000000 USD
CY2018Q4 ci Unearned Premiums Noncurrent
UnearnedPremiumsNoncurrent
379000000 USD
CY2018Q4 us-gaap Policyholder Contract Deposits
PolicyholderContractDeposits
8006000000 USD
CY2018Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
9721000000 USD
CY2018Q4 us-gaap Unearned Premiums
UnearnedPremiums
727000000 USD
CY2018Q4 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
26775000000 USD
CY2018Q4 ci Reinsurance Recoverables Non Current
ReinsuranceRecoverablesNonCurrent
5507000000 USD
CY2018Q4 us-gaap Investments
Investments
28974000000 USD
CY2019Q1 us-gaap Investments
Investments
28919000000 USD
CY2018Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
1858000000 USD
CY2019Q1 us-gaap Investments In And Advances To Affiliates Amount Of Equity
InvestmentsInAndAdvancesToAffiliatesAmountOfEquity
0 USD
CY2019Q1 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
0 USD
CY2019Q1 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
0 USD
CY2018Q1 ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
-16000000 USD
CY2019Q1 ci Realized Investment Gain Loss Excluding Impairments
RealizedInvestmentGainLossExcludingImpairments
11000000 USD
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000000 USD
CY2018Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
131000000 USD
CY2019Q1 ci Revenue Transitioning Clients
RevenueTransitioningClients
4489000000 USD
CY2019Q1 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
28000000 USD
CY2019Q1 ci Segment Revenues
SegmentRevenues
33429000000 USD
CY2019Q1 ci Income Loss Attributable To Transitioning Clients Pretax
IncomeLossAttributableToTransitioningClientsPretax
660000000 USD
CY2019Q1 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
5000000 USD
CY2019Q1 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
38000000 USD
CY2019Q1 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1964000000 USD
CY2018Q1 ci Income Loss Attributable To Noncontrolling Interest Before Tax
IncomeLossAttributableToNoncontrollingInterestBeforeTax
4000000 USD
CY2018Q1 ci Realized Investment Gain Loss Including Equity Method Subsidiaries
RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries
-35000000 USD
CY2018Q1 ci Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1336000000 USD
CY2019Q1 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div><table style='border-collapse:collapse;' ><tr style='height:10.5pt;' ><td style='width:129pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:153pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >March 31, 2019</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td colspan='5' rowspan='1' style='width:153pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:153pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >December 31, 2018</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:58.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >March 31, 2018</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;border-bottom-style:solid;border-bottom-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-style:italic;color:#000000;' >(In millions)</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Current</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Non-current</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Total</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Current</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Non-current</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Total</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:58.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:center;vertical-align:bottom;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Total</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;border-top-style:solid;border-top-width:1;text-align:left;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Contractholder deposit funds</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >621</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >7,326</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >7,947</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >641</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >7,365</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >8,006</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:58.5pt;border-top-style:solid;border-top-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >8,153</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Future policy benefits</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >643</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >9,048</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >9,691</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >740</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >8,981</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >9,721</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:58.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >9,934</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;text-align:left;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >Unpaid claims and claim expenses</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:58.5pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Integrated Medical</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >2,943</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >18</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >2,961</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >2,678</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >19</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >2,697</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:58.5pt;text-align:right;vertical-align:bottom;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >2,638</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;text-align:left;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Other segments</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >2,421</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >3,304</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >5,725</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >2,394</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >3,230</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >5,624</font></td><td style='width:9pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:58.5pt;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >5,502</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:10.5pt;' ><td style='width:129pt;border-bottom-style:solid;border-bottom-width:1;text-align:left;vertical-align:bottom;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Unearned premiums</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >432</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >347</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >779</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >348</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >379</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:45pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >727</font></td><td style='width:9pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td><td style='width:58.5pt;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >1,291</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr><tr style='height:21pt;' ><td style='width:129pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:left;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:129pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >Total insurance and contractholder liabilities</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >7,060</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >20,043</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >27,103</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >6,801</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >19,974</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >$</font></td><td style='width:45pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:45pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >26,775</font></td><td style='width:9pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:9pt;' ><font style='font-family:Times New Roman;font-size:8pt;font-weight:bold;color:#000000;' >$</font></td><td style='width:58.5pt;border-top-style:solid;border-top-width:1;border-bottom-style:solid;border-bottom-width:1;text-align:right;vertical-align:bottom;background-color:#E6E0EC;border-color:Black;min-width:58.5pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' >27,518</font></td><td style='width:12.75pt;text-align:left;vertical-align:bottom;border-color:Black;min-width:12.75pt;' ><font style='font-family:Times New Roman;font-size:8pt;color:#000000;' ></font></td></tr></table></div>
CY2018Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
103000000 USD
CY2018Q1 ci Increase Decrease In Amounts Due To From Affiliates
IncreaseDecreaseInAmountsDueToFromAffiliates
0 USD
CY2018Q1 ci Intercompany Dividends Paid
IntercompanyDividendsPaid
0 USD
CY2019Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
194000000 USD
CY2019Q1 ci Increase Decrease In Amounts Due To From Affiliates
IncreaseDecreaseInAmountsDueToFromAffiliates
0 USD
CY2019Q1 ci Intercompany Dividends Paid
IntercompanyDividendsPaid
0 USD
CY2018Q4 us-gaap Investments In And Advances To Affiliates Amount Of Equity
InvestmentsInAndAdvancesToAffiliatesAmountOfEquity
0 USD
CY2018Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
0 USD
CY2018Q4 ci Insurance Customer Receivables
InsuranceCustomerReceivables
1888000000 USD
CY2018Q4 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable
4988000000 USD
CY2018Q4 ci Pharmaceutical Manufacturer Receivable
PharmaceuticalManufacturerReceivable
3321000000 USD
CY2018Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
276000000 USD
CY2018Q4 ci Pharmaceutical Manufacturer Rebate Noninsurance Customer
PharmaceuticalManufacturerRebateNoninsuranceCustomer
406000000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
58000000 USD
CY2018Q1 ci Realized Investment Losses Commercial Mortgage Loans Real Estate Entities Certain Equity Securities
RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecurities
USD
CY2019Q1 ci Realized Investment Losses Commercial Mortgage Loans Real Estate Entities Certain Equity Securities
RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecurities
0 USD
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
22136000000 USD
CY2019Q1 us-gaap Separate Account Assets
SeparateAccountAssets
8079000000 USD
CY2019Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
9971000000 USD
CY2018Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
8999000000 USD
CY2019Q1 us-gaap Net Investment Income
NetInvestmentIncome
346000000 USD
CY2018Q1 us-gaap Net Investment Income
NetInvestmentIncome
329000000 USD
CY2019Q1 us-gaap Revenues
Revenues
37946000000 USD
CY2018Q1 us-gaap Revenues
Revenues
11413000000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24050000000 USD
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
561000000 USD
CY2019Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
7620000000 USD
CY2018Q1 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
6772000000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3303000000 USD
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2745000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
743000000 USD
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000 USD
CY2019Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
35716000000 USD
CY2018Q1 us-gaap Benefits Losses And Expenses
BenefitsLossesAndExpenses
10105000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2230000000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1308000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-452000000 USD
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000000 USD
CY2019Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
10000000 USD
CY2018Q1 ci Realized Investment Gain Loss
RealizedInvestmentGainLoss
-33000000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1788000000 USD
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1218000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
416000000 USD
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
301000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
1372000000 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
917000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 USD
CY2018Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1368000000 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
915000000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.61
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.78
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.72
CY2018Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-284000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
45000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-13000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-226000000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
689000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
442000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-11000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
429000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1797000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
3000000 USD
CY2018Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
2000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
1000000 USD
CY2018Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
0 USD
CY2019Q1 ci Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest Redeemable
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterestRedeemable
-2000000 USD
CY2018Q1 ci Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest Redeemable
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterestRedeemable
-2000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1799000000 USD
CY2018Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
689000000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
39003000000 USD
CY2018Q4 ci Pharmacy And Service Costs Payable
PharmacyAndServiceCostsPayable
10702000000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4366000000 USD
CY2018Q4 ci Accrued Expenses And Other Liabilities
AccruedExpensesAndOtherLiabilities
7071000000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9453000000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
7000000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4976000000 USD
CY2019Q1 us-gaap Short Term Investments
ShortTermInvestments
1662000000 USD
CY2019Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
10941000000 USD
CY2019Q1 us-gaap Inventory Net
InventoryNet
2382000000 USD
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1175000000 USD
CY2019Q1 us-gaap Assets Current
AssetsCurrent
21136000000 USD
CY2019Q1 us-gaap Long Term Investments
LongTermInvestments
27257000000 USD
CY2019Q1 ci Reinsurance Recoverables Non Current
ReinsuranceRecoverablesNonCurrent
5385000000 USD
CY2019Q1 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
2817000000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4523000000 USD
CY2019Q1 us-gaap Goodwill
Goodwill
44537000000 USD
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38338000000 USD
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2276000000 USD
CY2019Q1 us-gaap Assets
Assets
154348000000 USD
CY2019Q1 ci Insurance And Contractholder Liabilities Current
InsuranceAndContractholderLiabilitiesCurrent
7060000000 USD
CY2019Q1 ci Pharmacy And Service Costs Payable
PharmacyAndServiceCostsPayable
11145000000 USD
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4488000000 USD
CY2019Q1 ci Accrued Expenses And Other Liabilities
AccruedExpensesAndOtherLiabilities
7361000000 USD
CY2019Q1 us-gaap Debt Current
DebtCurrent
2915000000 USD
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
32969000000 USD
CY2019Q1 ci Insurance And Contractholder Liabilities Noncurrent
InsuranceAndContractholderLiabilitiesNoncurrent
20043000000 USD
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
9403000000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3832000000 USD
CY2019Q1 us-gaap Separate Accounts Liability
SeparateAccountsLiability
8079000000 USD
CY2019Q1 us-gaap Liabilities
Liabilities
111897000000 USD
CY2019Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
38000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
42408000000 USD
CY2019Q1 us-gaap Minority Interest
MinorityInterest
5000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42413000000 USD
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154348000000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
4000000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27751000000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1711000000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15088000000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
104000000 USD
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
4000000 USD
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27855000000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1282000000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16426000000 USD
CY2019Q1 us-gaap Treasury Stock Value
TreasuryStockValue
595000000 USD
CY2019Q1 ci Shareholders Equity Per Share
ShareholdersEquityPerShare
111.52
CY2018Q4 ci Shareholders Equity Per Share
ShareholdersEquityPerShare
107.71
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
140000000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-9000000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
53000000 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-94000000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
76000000 USD
CY2018Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-51000000 USD
CY2018Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
849000000 USD
CY2018Q1 ci Increase Decrease In Pharmacy And Service Costs Payable
IncreaseDecreaseInPharmacyAndServiceCostsPayable
-124000000 USD
CY2018Q1 ci Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
193000000 USD
CY2018Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8000000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2025000000 USD
CY2018Q1 ci Proceeds From Sale Of Debt And Equity Securities
ProceedsFromSaleOfDebtAndEquitySecurities
499000000 USD
CY2018Q1 ci Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
297000000 USD
CY2018Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
28000000 USD
CY2018Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
112000000 USD
CY2018Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
2259000000 USD
CY2018Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
68000000 USD
CY2018Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
206000000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103000000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1700000000 USD
CY2018Q1 us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
292000000 USD
CY2018Q1 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
306000000 USD
CY2018Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-3000000 USD
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
310000000 USD
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000000 USD
CY2018Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-92000000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-530000000 USD
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4000000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-201000000 USD
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
31000000 USD
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
46000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3192000000 USD
CY2019Q1 ci Proceeds From Sale Of Debt And Equity Securities
ProceedsFromSaleOfDebtAndEquitySecurities
1471000000 USD
CY2019Q1 ci Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities
319000000 USD
CY2019Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
89000000 USD
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
367000000 USD
CY2019Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1088000000 USD
CY2019Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
95000000 USD
CY2019Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
388000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
475000000 USD
CY2019Q1 us-gaap Additions To Contract Holders Funds
AdditionsToContractHoldersFunds
247000000 USD
CY2019Q1 us-gaap Withdrawal From Contract Holders Funds
WithdrawalFromContractHoldersFunds
251000000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1048000000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
462000000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53000000 USD
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-73000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2534000000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1121000000 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2771000000 USD
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6000000 USD
CY2018Q1 ci Transaction Related Costs
TransactionRelatedCosts
60000000 USD
CY2019Q1 ci Transaction Related Costs
TransactionRelatedCosts
136000000 USD
CY2019Q1 ci Transaction Related Costs After Tax
TransactionRelatedCostsAfterTax
108000000 USD
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
900000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2800000 shares
CY2018Q1 us-gaap Policyholder Contract Deposits
PolicyholderContractDeposits
8153000000 USD
CY2018Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
9934000000 USD
CY2018Q1 us-gaap Unearned Premiums
UnearnedPremiums
1291000000 USD
CY2018Q1 ci Insurance And Contractholder Liabilities
InsuranceAndContractholderLiabilities
27518000000 USD
CY2019Q1 ci Non Investment Revenue
NonInvestmentRevenue
37600000000 USD
CY2018Q1 ci Non Investment Revenue
NonInvestmentRevenue
11084000000 USD
CY2018Q1 ci Segment Revenues
SegmentRevenues
11415000000 USD
CY2019Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
59000000 USD
CY2018Q1 us-gaap Reinsurance Effect On Claims And Benefits Incurred Amount Ceded
ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
104000000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1086000000 USD
CY2018Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
499000000 USD
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
14000000 USD
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
5000000 USD
CY2019Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
10000000 USD
CY2018Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
22000000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
379387000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4637000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
384024000 shares
CY2019Q1 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.05
CY2018Q1 ci Earnings Per Share Effect Of Dilution
EarningsPerShareEffectOfDilution
-0.06
CY2018Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
242179000 shares
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3609000 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
245788000 shares
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
75000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
429000000 USD
CY2019Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1369000000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15000000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
462000000 USD
CY2019Q1 ci Noncontrolling Interest Other Changes
NoncontrollingInterestOtherChanges
-3000000 USD
CY2019Q1 ci Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
-2000000 USD
CY2019Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
3000000 USD
CY2019Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-15000000 USD
CY2018Q1 ci Tax Cuts And Jobs Act Of2017 Reclassification From Aoci Tax Effect
TaxCutsAndJobsActOf2017ReclassificationFromAociTaxEffect
0 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-226000000 USD
CY2018Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
915000000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14195000000 USD
CY2018Q1 ci Temporary Equity Other Comprehensive Income
TemporaryEquityOtherComprehensiveIncome
-2000000 USD
CY2018Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
2000000 USD
CY2018Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
49000000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
897000000 USD
CY2019Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
162000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
396000000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-440000000 USD
CY2019Q1 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
51000000 USD
CY2019Q1 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-124000000 USD
CY2019Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
360000000 USD
CY2019Q1 ci Increase Decrease In Pharmacy And Service Costs Payable
IncreaseDecreaseInPharmacyAndServiceCostsPayable
444000000 USD
CY2019Q1 ci Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities
91000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-83000000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
29000000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
377000000 USD
CY2018Q4 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
0 USD
CY2019Q1 us-gaap Derivative Term Of Contract
DerivativeTermOfContract
P3M
CY2018Q1 us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
USD
CY2019Q1 us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
USD
CY2018Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
USD
CY2019Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
USD
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
USD
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
USD
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
USD
CY2019Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
USD
CY2018Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
USD
CY2019Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
USD
CY2018Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
USD
CY2019Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
USD
CY2019Q1 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
5665000000 USD
CY2018Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
5804000000 USD
CY2019Q1 ci Reinsurance Recoverables Current
ReinsuranceRecoverablesCurrent
280000000 USD
CY2018Q4 ci Reinsurance Recoverables Current
ReinsuranceRecoverablesCurrent
297000000 USD
CY2019Q1 us-gaap Ceded Premiums Earned
CededPremiumsEarned
130000000 USD
CY2018Q1 us-gaap Ceded Premiums Earned
CededPremiumsEarned
135000000 USD
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233 pure
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247 pure
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
42000000 USD
CY2019Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000000 USD
CY2019Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6000000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
26000000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
45000000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
602000000 USD
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160000000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
524000000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
684000000 USD
CY2019Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
89000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
129000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
169000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
140000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
121000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
81000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
124000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
764000000 USD
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
80000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
18000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
23000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
14000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
14000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
9000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
22000000 USD
CY2019Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
100000000 USD
CY2019Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
11000000 USD
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2019Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2019Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
38000000 USD
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10000000 USD
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
275000000 USD
CY2018Q1 ci Noncontrolling Interest Other Changes
NoncontrollingInterestOtherChanges
0 USD
CY2019Q1 ci Debt And Equity Securities Classified In Level2 Percentage
DebtAndEquitySecuritiesClassifiedInLevel2Percentage
0.97 pure
CY2019Q1 ci Debt And Equity Securities Classified In Level3 Percentage
DebtAndEquitySecuritiesClassifiedInLevel3Percentage
0.02 pure
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
21000000 USD
CY2019Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
68000000 USD
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0388 pure
CY2019Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0386 pure
CY2019Q1 ci Insurance Customer Receivables
InsuranceCustomerReceivables
2261000000 USD
CY2019Q1 ci Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable
NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable
4635000000 USD
CY2019Q1 ci Pharmaceutical Manufacturer Receivable
PharmaceuticalManufacturerReceivable
3682000000 USD
CY2019Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
363000000 USD
CY2019Q1 ci Pharmaceutical Manufacturer Rebate Noninsurance Customer
PharmaceuticalManufacturerRebateNoninsuranceCustomer
624000000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
456000000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
217000000 USD
CY2018Q1 ci Realized Investment Gains Losses Equity Method Investments
RealizedInvestmentGainsLossesEquityMethodInvestments
-2000000 USD
CY2019Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
USD
CY2018Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
USD
CY2019Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
37571000000 USD
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
39523000000 USD
CY2019Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
91000000 USD
CY2019Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
ci:AccruedExpensesAndOtherLiabilities
CY2019Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentNet
CY2019Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:DebtCurrent
CY2019Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2019Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2019Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
0 USD
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
384000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
381000000 shares
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2019Q1 ci Loans Due From Affiliates Net
LoansDueFromAffiliatesNet
0 USD
CY2018Q1 ci Loans Due From Affiliates Net
LoansDueFromAffiliatesNet
0 USD
CY2018Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
32000000 USD

Files In Submission

Name View Source Status
0001104659-19-026396-index-headers.html Edgar Link pending
0001104659-19-026396-index.html Edgar Link pending
0001104659-19-026396.txt Edgar Link pending
0001104659-19-026396-xbrl.zip Edgar Link pending
a19-9011_110q.htm Edgar Link pending
a19-9011_1ex10d1.htm Edgar Link pending
a19-9011_1ex10d2.htm Edgar Link pending
a19-9011_1ex10d3.htm Edgar Link pending
a19-9011_1ex10d4.htm Edgar Link pending
a19-9011_1ex31d1.htm Edgar Link pending
a19-9011_1ex31d2.htm Edgar Link pending
a19-9011_1ex32d1.htm Edgar Link pending
a19-9011_1ex32d2.htm Edgar Link pending
ci-20190331.xml Edgar Link completed
ci-20190331.xsd Edgar Link pending
ci-20190331_cal.xml Edgar Link unprocessable
ci-20190331_def.xml Edgar Link unprocessable
ci-20190331_lab.xml Edgar Link unprocessable
ci-20190331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending